English
CAVI-T: THE UNIVERSAL INTRANASAL BALLOON
A novel approach for an atraumatic management of intranasal bleeding. Controlling anterior and posterior epistaxis with an universal reference.
CAVI-T® Advantages
Optimal Treatment
Treatment of anterior and posterior bleeding with low pressure balloon technology
Rapid Control
90% of patients achieve bleeding control at 1h10, with guided and controlled positioning
Professional Care
Homogeneous compression of the nasal cavity reducing blood secretions
Advantages for Healthcare Professionals
Treatment of anterior and posterior bleeding- Low pressure balloon allowing optimal conformation to the anatomy
- Easy insertion with alignment markers for guided and controlled positioning
- Rapid control of bleeding (90% of patients at 1h)
- Homogeneous compression of the nasal cavity allowing the reduction of blood secretions
- Functions in complex cases (e.g. elderly coagulopathic population)
- Designed to promote ambulatory care
- Potential to reduce readmission rates
- Distancing between the patient and healthcare professional
Quality of Life Improvement
Patient Benefits
Reduced pain upon removal (1.6 / 10 on VAS*)
Breathing channel
Visually discreet product
Rapid return to daily life activities
Removal by a home-care nurse
Clinical Evidence
Pilot clinical trial of an asymmetrical balloon (CAVI-T™) in the treatment of intranasal bleeding in adult patients managed in an emergency setting.
C Debry et al. Manuscript submitted to Rhinology Online on May 4th, 2020.
*VAS = Visual Analogue Scale